AusCADASIL: An Australian Cohort of CADASIL
ConditionCadasil
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorPerminder Sachdev
About this trial
The aim of this project is to establish an Australian cohort of patients diagnosed with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL). This study will examine the clinical features and longitudinal course of CADASIL. Outcome measures include neuropsychological profile, neuroimaging, genetics, blood biomarkers, and retinal imaging.
Eligibility criteria
Qualifiers
Adults ≥18 years old
Ability to provide written informed consent
A large-print version is available for individuals with visual impairment
An easy-to-read version is available for individuals with cognitive difficulties who may require extra support
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsSponsors and collaborators
Perminder Sachdev
Lead sponsor
The University of New South Wales
Sponsor institution
Prince of Wales Hospital, Sydney
Collaborator
John Hunter Hospital
Collaborator
St Vincent's Hospital - Sydney, Australia
Collaborator
Royal Brisbane and Women's Hospital
Collaborator
Melbourne Health
Collaborator
The University of Queensland
Collaborator
Source ClinicalTrials.gov